Micro and Nano-Systems for Medicine and Public Safety

The future of biology and medicine lies at the intersection of engineering, materials science, chemistry, and nanotechnology. In particular, the fields of micro/nanoscale technologies have seen an unprecedented growth and development over the last decade. In this domain, I have been developing cutting-edge micro and nanoscale technologies to present precise solutions for real-world problems in biology and medicine, thereby improving human health and advancing public safety. Particularly, I develop innovative, user-friendly, ultra-sensitive, and specific diagnostic and therapeutic screening platforms in the fields of early cancer detection, infectious diseases, biomarker discovery, as well as forensics science. I also present innovative mobile health approaches on a daily-basis that would potentially report disease status of patients to physicians and nurses, accelerating the screening of individuals and minimizing health disparities at the remote settings. In this regard, I precisely manipulate biomolecules, cells, and viruses in small volumes, and integrate microscale tools with multifunctional nanotechnology modalities to record minute amount of biological signals at their native milieu. Furthermore, I aim to leverage these approaches for bed-side, where individuals can easily self-monitor their health status for personalized and precision medicine applications. All these examples from my research aim to push the limits of cell manipulations and engineering tools in order to provide real solutions to problems in the clinic.

About The Speaker

Dr. Fatih Inci is currently working as a research scientist at the Department of Radiology, Canary Center at Stanford, Stanford University School of Medicine. He has completed his postdoctoral training at Stanford University School of Medicine and Harvard Medical School-Brigham & Women’s Hospital (BWH). During his doctoral studies, Dr. Inci was appointed as a visiting scientist at School of Biotechnology and Biomolecular Sciences, University of New South Wales and Institute for Nanoscale Technology, University of Technology Sydney. In addition, he worked as a research scholar at Harvard Medical School-BWH and Harvard-Massachusetts Institute of Technology (MIT) – Health Sciences and Technology. Dr. Inci received his Ph.D. degree from the Department of Molecular Biology-Genetics & Biotechnology, Istanbul Technical University. He completed his B.Sc. studies at the Department of Molecular Biology and Genetics, Istanbul University, and also studied as an Erasmus/Socrates Exchange student at the Department of Biology, University of Groningen.